Found: 149
Select item for more details and to access through your institution.
Survival in Elderly Ovarian Cancer Remains Challenging in the Nordic Countries.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2198, doi. 10.3390/cancers16122198
- By:
- Publication type:
- Article
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7126
- By:
- Publication type:
- Article
Major improvement in thyroid cancer survival of elderly patients in the Nordic countries.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 3, p. K32, doi. 10.1093/ejendo/lvae015
- By:
- Publication type:
- Article
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6867
- By:
- Publication type:
- Article
Conditional survival in breast cancer up to 10 years in the Nordic countries.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17945, doi. 10.1002/cam4.6436
- By:
- Publication type:
- Article
Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4261, doi. 10.3390/cancers15174261
- By:
- Publication type:
- Article
Early mortality critically impedes improvements in thyroid cancer survival through a half century.
- Published in:
- European Journal of Endocrinology, 2023, v. 189, n. 3, p. 355, doi. 10.1093/ejendo/lvad117
- By:
- Publication type:
- Article
Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4132, doi. 10.3390/cancers15164132
- By:
- Publication type:
- Article
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171083
- By:
- Publication type:
- Article
Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries.
- Published in:
- Obstetrics & Gynecology International, 2023, p. 1, doi. 10.1155/2023/6909414
- By:
- Publication type:
- Article
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3092, doi. 10.3390/cancers15123092
- By:
- Publication type:
- Article
Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2782, doi. 10.3390/cancers15102782
- By:
- Publication type:
- Article
Survival in gastric and esophageal cancers in the Nordic countries through a half century.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10212, doi. 10.1002/cam4.5748
- By:
- Publication type:
- Article
Survival in Lung Cancer in the Nordic Countries Through A Half Century.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 503, doi. 10.2147/CLEP.S406606
- By:
- Publication type:
- Article
Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 9, p. 1837, doi. 10.1002/ijc.34416
- By:
- Publication type:
- Article
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 8, p. 1227, doi. 10.1002/cncr.34663
- By:
- Publication type:
- Article
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 6, p. 1107, doi. 10.1002/ijc.34308
- By:
- Publication type:
- Article
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 648, doi. 10.3390/cancers15030648
- By:
- Publication type:
- Article
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 991, doi. 10.3390/cancers15030991
- By:
- Publication type:
- Article
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers.
- Published in:
- Diseases, 2022, v. 10, n. 3, p. N.PAG, doi. 10.3390/diseases10030052
- By:
- Publication type:
- Article
Long‐term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 4, p. 510, doi. 10.1002/ijc.34031
- By:
- Publication type:
- Article
Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 2, p. 200, doi. 10.1002/ijc.33980
- By:
- Publication type:
- Article
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1938, doi. 10.3390/cancers14081938
- By:
- Publication type:
- Article
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.794251
- By:
- Publication type:
- Article
Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261124
- By:
- Publication type:
- Article
Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Types of second primary cancer influence overall survival in cutaneous melanoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Familial Risks and Proportions Describing Population Landscape of Familial Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4385, doi. 10.3390/cancers13174385
- By:
- Publication type:
- Article
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers.
- Published in:
- Clinical Epidemiology, 2021, v. 13, p. 683, doi. 10.2147/CLEP.S318737
- By:
- Publication type:
- Article
Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.706517
- By:
- Publication type:
- Article
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.
- Published in:
- Clinical Epidemiology, 2021, v. 13, p. 515, doi. 10.2147/clep.s318737
- By:
- Publication type:
- Article
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0253236
- By:
- Publication type:
- Article
Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.674400
- By:
- Publication type:
- Article
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 978, doi. 10.3390/cells10050978
- By:
- Publication type:
- Article
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 246, doi. 10.3390/cells10020246
- By:
- Publication type:
- Article
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 8258, doi. 10.1002/cam4.3454
- By:
- Publication type:
- Article
Cancer Predisposition Genes in Cancer-Free Families.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2770, doi. 10.3390/cancers12102770
- By:
- Publication type:
- Article
Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues.
- Published in:
- Clinical Epidemiology, 2020, v. 12, p. 857, doi. 10.2147/CLEP.S256662
- By:
- Publication type:
- Article
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example.
- Published in:
- Hereditary Cancer in Clinical Practice, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s13053-020-00146-x
- By:
- Publication type:
- Article
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 4, p. 625, doi. 10.1111/pcmr.12868
- By:
- Publication type:
- Article
Oncolytic viruses for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00922-1
- By:
- Publication type:
- Article
TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 4, p. 798, doi. 10.3390/cells9040798
- By:
- Publication type:
- Article
Second primary cancers in non‐Hodgkin lymphoma: Family history and survival.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 4, p. 970, doi. 10.1002/ijc.32391
- By:
- Publication type:
- Article
Second Primary Cancers in Melanoma Patients Critically Shorten Survival.
- Published in:
- Clinical Epidemiology, 2020, v. 12, p. 105, doi. 10.2147/CLEP.S230149
- By:
- Publication type:
- Article
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 232, doi. 10.1111/bjh.15777
- By:
- Publication type:
- Article
Second primary cancer after female breast cancer: Familial risks and cause of death.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 400, doi. 10.1002/cam4.1899
- By:
- Publication type:
- Article
Second primary cancers in non‐Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 10, p. 2449, doi. 10.1002/ijc.31801
- By:
- Publication type:
- Article
Familial Risks and Mortality in Second Primary Cancers in Melanoma.
- Published in:
- JNCI Cancer Spectrum, 2018, v. 2, n. 4, p. N.PAG, doi. 10.1093/jncics/pky068
- By:
- Publication type:
- Article